Most health care workers (HCW), Emergency Physicians especially, understand the nearly daily changing nature of the current COVID-19 pandemic and the associated recommendations for care and evaluations. Since publication of "COVID-19 Personal Protective Equipment (PPE) for the Emergency Physician" *Visual Journal of Emergency Medicine* 19 (2020) 100740, two important changes have been published from the US Occupational Health and Safety Administration (OSHA) and from the US Center for Disease Control and Prevention (CDC). This addendum serves to explain and clarify this updated information.

Since N95 masks are in critically short supply in the USA and worldwide, OSHA has temporarily suspended the yearly fit test requirement for HCW using N95 masks. The new guidance advises employers should "Inform workers that the employer is temporarily suspending the annual fit testing of N95 filtering facepiece respirators to preserve and prioritize the supply of respirators for use in situations where they are required to be worn." The initial fit testing of a new employee is not waved and still needs to be performed. (ref: <https://www.osha.gov/memos/2020-03-14/temporary-enforcement-guidance-healthcare-respiratory-protection-annual-fit>)

The second new development since the original article\'s publication is the clarification from the US CDC that COVID-19 disease spreads primarily by droplets, and therefore additional guidance and clarification was issued explaining when surgical or procedure face masks are adequate and when an N95 respirator is required. It is currently believed that COVID-19 is primarily spread via respiratory droplets, like influenza, and a recent study demonstrated that surgical masks or procedure masks offer adequate protection for HCW under normal patient care scenarios for influenza (see reference \#13 from original article: Radonovich LJ Jr, Simberkoff MS, et al., "ResPECT investigators. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial", *JAMA* 2019 Sep. 3;322(9):824--833). This evidence makes it likely that these same procedure/surgical mask should offer adequate protection as well. Specifically, the CDC identified the shortage of N95 respirators and that surgical and procedure-type facemasks are an acceptable alternative when the supply chain of respirators cannot meet the demand. During this time, available N95 respirators should be prioritized for procedures that are likely to generate respiratory aerosols (e.g., sputum induction, open suctioning of airways, bronchoscopy, etc.) which would pose the highest exposure risk to HCP. When the supply chain is restored, facilities with a respiratory protection program should return to use of N95 (or equivalent) respirators for patients with known or suspected COVID-19. (ref: <https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html>)
